BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

AlzeCure Implements Vortex To Enhance Research Efforts In Alzheimer's Disease


12/11/2013 9:35:55 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BISHOPS STORTFORD, England, December 11, 2013 /PRNewswire/ --

Dotmatics' Vortex to be used to uncover new drug lead compounds for Alzheimer's disease

Dotmatics, a leading provider of scientific informatics solutions and services to the pharmaceutical and biotechnology industries, announced today that the research foundation AlzeCure, has deployed and integrated the data visualization and analysis tool Vortex. AlzeCure is a novel innovative drug discovery unit that will use Vortex to help in the quest to discover and develop novel therapies for the treatment of Alzheimer's disease and other neurodegenerative disorders.

Dotmatics' Vortex is a dynamic analytic and visualization tool designed specifically for the analysis and interrogation of scientific data including chemical structures, biological assays, text, numbers, images and chemical properties. Vortex provides users with an out-of the-box filtering, charting, plotting and chemically aware calculation engine, thus enabling scientists to evaluate large datasets in a rich, intuitive and flexible user interface. The use of Vortex helps to uncover hidden data trends and correlations, consequently identifying new potential drug candidates.

After extensive testing, AlzeCure selected Dotmatics' Vortex because of its "extensive visualization functionality and analysis algorithms, ease of use, and ability to run on Mac OS X as well as Windows," says Dr. Gunnar Nordvall, Head of Medicinal and Computational Chemistry at AlzeCure. "We can rapidly evaluate results from us and our partners and it enables us to make quick decisions about our candidate compounds."

"Research at AlzeCure aims to tackle a devastating disease. We are pleased to have been chosen as the informatics platform to help accelerate the discovery of new drugs to treat Alzheimer's disease," said Dr. Mike Hartshorn, CSO of Dotmatics. "We continue our path of strong investment in Vortex to make sure that it continues to be the best data analysis and visualization tool for scientists."

About Dotmatics:

At the forefront of innovation, Dotmatics is a leading global scientific informatics software and services provider, delivering solutions tailored to the modern, highly collaborative and mobile pharmaceutical, biotechnology and chemical industries as well as academia. Dotmatics' enterprise solutions are flexible, scalable and configurable, providing effective scientific information management across entire organizations, from discovery research to development and early manufacturing. Dotmatics has significant expertise in scientific informatics, including database management for chemistry and biologics, electronic laboratory notebooks, chemical and biological registration, screening data management, SAR analysis, reporting, and visualization. Dotmatics solutions are available for local or cloud deployment and they are supported on Microsoft Windows, Mac OS X and Linux. A privately owned company, Dotmatics was founded in 2005 and their headquarters is based south of Cambridge in the UK.

Enquiries:

Mariana Vaschetto

Dotmatics Limited

Tel (Europe): +44(0)1279-654-123

Tel (US West Coast): +1(619)419-2808

Tel (US East Coast): +1(781)281-2330

Fax: +44(0)1279-653-088

Email: mv@dotmatics.com

Website: http://www.dotmatics.com

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES